Dr. Sigrid Carlsson is Director of Clinical Research at MSK's Josie Robertson Surgery Center and Assistant Attending Epidemiologist in MSK's Departments of Surgery (Urology Service) and Epidemiology and Biostatistics. Her line of research focuses on screening and early detection of prostate cancer, including multiplex testing and risk-stratified strategies that incorporate clinical information, biomarkers and MRI, as recently funded by a NCI U01 award. She also holds an appointment as Associate Professor of Experimental Urology, Gothenburg University, in Sweden where she is an investigator of two large randomized controlled trials of prostate cancer screening (GOTEBORG-1&2), as recently published in the New England Journal of Medicine. She is also an Adjunct Senior Lecturer at Lund University in Sweden. She serves on the NCCN and AUA guidelines for early detection of prostate cancer and was the methodologist for the Prostate Cancer Foundation's guideline on prostate cancer screening for Black men in the US. She recently received the Platinum Award from the European Association of Urology. Her Prevent Cancer Foundation funded research has focused on developing a decision support tool for prostate cancer screening using innovative technology.